Autoimmunity BioSolutions is a biotechnology company focused on developing next-generation immuno-corrective therapies for patients with autoimmune diseases. The company targets a genetically-defined subpopulation, aiming to address the underlying causes of these conditions with innovative treatments.
Leadership & Board
Current Number of Employees7
Current LinkedIn Followers116
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$2M
Total Amount Raised$2M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$2M
Latest Funding Amount$2M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Autoimmunity BioSolutions had 7 employees as of March 23, 2026. The number of employees increased by 0 (0.00%) week-over-week.
7Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Autoimmunity BioSolutions had 116 followers as of March 23, 2026. The number of followers increased by 2 (1.75%) week-over-week.
116Latest Followers Count
2(1.75%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.